Podcasts about OTC

Send us a textStruggling to catch every word or feeling like voices are loud but still muddy? We unpack the real differences between over-the-counter hearing aids and prescription fittings, focusing on when each path makes sense and how to get results you can actually feel in daily life. Drawing on clinical standards and FDA guidance, we map clear criteria for safe OTC use, the red flags that call for an audiologist or ENT, and why a baseline hearing test is one of the most valuable health checks you can get.We walk through what a prescription fit includes—diagnostic testing, individualized programming, and real-ear verification—so you understand how precise tuning translates into sharper speech clarity. Then we contrast that with self-fit OTC devices: accessible, affordable, and helpful for some adults with mild hearing loss, but limited by generalized amplification and lack of objective verification. You'll hear why noise is the top complaint across users, how directionality and signal processing drive comprehension more than raw volume, and how realistic expectations, coaching, and follow-up shape satisfaction.Along the way, a simple vision-care analogy brings the trade-offs to life: readers can help in a pinch, but complex needs benefit from a tailored prescription. We also look ahead at how AI is enhancing hearing care without replacing the professional, and how OTC options have expanded awareness while underscoring the value of expert guidance. If you're wondering whether to start with an OTC device or book a comprehensive evaluation, this conversation gives you the clarity to choose confidently—and the next steps to take.If this helped you make sense of your options, follow the show, share it with someone who's hesitating on hearing help, and leave a quick review so others can find it too.Connect with the Hearing Matters Podcast TeamEmail: hearingmatterspodcast@gmail.com Instagram: @hearing_matters_podcast Facebook: Hearing Matters Podcast

Primary season is here, and District 37 voters are weighing real tradeoffs: how do we make life more affordable, strengthen public schools, and restore trust in state government? We brought all three Democratic candidates—Ralph Clements, Wynn Decker, and Marcus Gadson—into one room for a substantive, fast-moving forum that gets specific on budgets, vouchers, healthcare, and the path to a flipped seat in Southern Wake County. These candidates are vying for the chance to run against incumbent Erin Pare come November to be elected into the NC House of Representatives.  We start with clarity on voting: who gets which ballot, how to confirm your districts with the NCSBE Voter Search, and why printing a sample ballot can calm “test anxiety” at the polls. Then, the forum begins, and we turn to policy. On education, candidates confront the voucher surge, teacher pay, capital needs like HVAC and tech, and how to keep special education services strong. You'll hear competing strategies to restore voucher income caps, require private schools taking public funds to publish test scores, and freeze or tighten voucher growth until public schools are fully funded.Affordability threads through everything: proposals to reinstate the earned income tax credit, cut taxes on essentials like OTC meds and prepared foods, and boost housing supply with duplexes, triplexes, and ADUs. Property tax fairness and better infrastructure funding round out a pragmatic approach to costs families feel every day. The healthcare segment spotlights Medicaid reimbursement rates, mental health capacity, hospital price transparency, and protecting reproductive freedom—with calls to secure choice through state constitutional safeguards.Undergirding it all is the health of democracy: breaking budget gridlock, protecting the governor's veto, and reforming redistricting so general elections—not just primaries—shape policy. If you want clear contrasts, concrete ideas, and an honest look at how to actually pass laws in Raleigh, this forum delivers.Subscribe to NC Deep Dive Podcast, share this episode with a neighbor, and leave a review so more voters can find it. Your voice shapes the outcome—what's the one change you want your next representative to prioritize?Support the showAs always, if you are interested in being on or sponsoring the podcast or if you have any particular issues, thoughts, or questions you'd like explored on the podcast, please email NCDeepDive@gmail.com. Your contributions would be greatly appreciated.Now, let's dive in!

Send us a textBuying hearing help shouldn't feel like guesswork. We break down over-the-counter hearing aids with plain talk: what they are, who they're designed for, and how to know whether self-fit amplification is a smart starting point or a detour that delays the clarity you want. You'll hear the critical differences between OTC and prescription devices, from diagnostic testing and individualized programming to real-ear verification and ongoing counseling that actually moves the needle in noisy, real-world settings.We share evidence-backed criteria to decide if OTC suits your needs—perceived mild to moderate loss, comfort managing tech, and realistic expectations—and the red flags that call for a professional evaluation right away, like sudden or asymmetric changes, persistent ringing or pain, or continued trouble understanding speech even when it's loud. Along the way, we talk through the biggest complaint users have in daily life: speech in noise. You'll learn why clarity, not just volume, drives satisfaction, and how targeted signal processing and guided adaptation can turn “I can hear” into “I can understand.”This conversation is about access and outcomes, not choosing sides. Used as directed, OTC devices are safe and can reduce stigma and encourage earlier engagement. The real risk is delay—waiting years to act or assuming nothing works after a poor first try. If you're on the fence, start with our online hearing test to get a baseline, then use our provider locator to find a professional who will meet you where you are, explain your hearing test results, and map options without pressure. Subscribe, share this with someone who keeps asking for repeats, and leave a review to help more people hear life's story with confidence.Omega AI hearing aids don't just keep up. They redefine what it means to be modern and discreet yet durable and comfortable for all-day wear.They're waterproof, everyday-proof, and designed to go the distance of your day and then some. All while tailored to your unique hearing needs. Connect with the Hearing Matters Podcast TeamEmail: hearingmatterspodcast@gmail.com Instagram: @hearing_matters_podcast Facebook: Hearing Matters Podcast

In the latest All In For Citrus podcast, Michael Rogers, director of the University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) Citrus Research and Education Center, discussed a statewide citrus workshop hosted at the Southwest Florida Research and Education Center in January. The event provided a day full of educational presentations covering a wide range of topics. Rogers noted several of the talks explained how HLB impacts citrus trees internally and how certain therapies help counteract those effects. Ute Albrecht, UF/IFAS associate professor of plant physiology, also joined the podcast to discuss her research on the use of oxytetracycline (OTC). Albrecht reported the yield results from a fairly large trial in a commercial Hamlin grove that has had three applications of OTC. The trial results reinforce the thinking that OTC has a cumulative effect over the course of several years as root systems get reestablished and tree health returns. The third-year yield data show significant yield increases in OTC-treated trees compared to controls. Davie Kadyampakeni, UF/IFAS associate professor of citrus water and nutrient management, summarized the take-home messages from his presentation at the workshop, which focused on optimizing citrus nutrition. A key point was to ensure nutrition is always available to citrus trees and in amounts that the trees can actually take up due to reduced root systems from HLB. This is even true with slow-release fertilizers. He recommended split applications throughout the year to ensure there is some overlap as one dose of slow-release fertilizer plays out. Kadyampakeni also gave a brief update on the status of new recommendations from UF/IFAS for citrus nutrition. He said there has been a slight delay in releasing the update but expects it will be coming soon.

NATO Flips, Trump Takes the Arctic | XRP & Bitcoin Buy the Dip? NATO just flipped. The Arctic is now center stage. And markets are reacting. From Davos openly admitting globalism is failing, to NATO leadership reversing course, to Trump pushing strategic leverage in the Arctic and Greenland — the global power structure is shifting fast. At the same time, cracks in the financial system are becoming impossible to ignore: • Banks exploiting settlement delays • Governments clawing back funds • Trust in institutions eroding So the real question becomes: is this fear… or opportunity? In this stream, we break down: • Why NATO's reversal matters more than headlines suggest • Why the Arctic and Greenland are suddenly strategic flashpoints • How Trump's deal-making approach is reshaping negotiations • What Davos didn't want to admit — and why it matters now • How XRP and Bitcoin fit into a world moving toward transparency • Whether this volatility signals a “buy the dip” moment or something deeper This isn't about left vs right. It's about power, leverage, money, and control in a system under stress.

Send us a textIn this episode of On The Pen: The Weekly Dose, Dave Knapp breaks down why the idea of over-the-counter GLP-1 medications isn't radical speculation, it's a pattern already in motion. Drawing on FDA signals, past regulatory precedent with Orlistat, recent pricing negotiations, softened safety language, and public comments from pharmaceutical executives, Dave lays out the case that low-dose oral GLP-1s could be the first step toward OTC access. This episode connects the dots between regulation, access, pricing, and normalization of obesity treatment, and explains why the people laughing today may be asking how they missed it tomorrow.

Chad Ryker talks with Erin Butler (AZ Game & Fish Big Game Program Supervisor) about Arizona's elk and pronghorn draw, how non-residents fit into tag allocation, and how to build a smart application strategy. They cover the 20% max-point pass / 80% random draw structure (meaning low-point hunters still have a real shot), highlight over-the-counter/non-permit elk options, and call out common application mistakes. They finish with deadlines, costs, bonus-point “boosters,” and Point Guard options.Key takeawaysAZ draw structure: 20% of tags go to max bonus point holders; 80% are in a random draw, so “everyone has a chance.”Non-resident cap: Typically 10% of tags per hunt can go to non-residents (with rules that keep some NR tags in the random portion).Low-point reality: Many non-residents who draw have low points; random pass can produce surprise “first-year” winners.OTC elk exists: Arizona has non-permit/over-the-counter elk opportunities (including HAM: handgun/archery/muzzleloader), but they're often tough/low success and require research.Big mistakes to avoid: Applying for hunts you're ineligible for (like single-tag hunts as a NR), picking the wrong weapon/season, and assuming longer seasons = better (sometimes longer = harder).Bonus point boosters: Hunter Ed point (permanent) + Loyalty point (apply 5 years straight; miss a year and it resets).Point Guard: Lets you turn back a tag and keep your points (not your money); Point Guard Plus can also put you on a list for turned-back tags.Costs & timing: Need the non-refundable license, then apply per species; elk/pronghorn apps run mid-January to early February (deadline around Feb 3, 11:59 PM). ARIZONA GAME AND FISH DEPARTMENTWebsite - https://www.azgfd.comInstagram - https://www.instagram.com/azgfd/Resources Draw Videohttps://www.azgfd.com/hunting/hunt-draw-and-licenses/big-game-draw/bonus-point-process/Elk Handout (and we do javelina too)https://www.azgfd.com/hunting/hunt-draw-and-licenses/tags/non-permit-tags/ OUT OF STATE HUNTER@outofstatehunter GOHUNTUse the code OUTOFSTATE when you become an Insider and get $50 in GOHUNT Gear Shop Credithttps://www.gohunt.com ARGALIWebsite -https://argalioutdoors.comInstagram - @argali_official - https://www.instagram.com/argali_official/ KAPTURE GEARWebsite –https://kapturegear.comInstagram - @kapturegear - https://www.instagram.com/kapturegear/  #outofstatehunter #westernhunting #huntplanning #biggamehunting #publiclandhunter #diyhunter #nonresidenthunting #huntstrategy #applicationseason #drawodds #elkseason #deerhunting #couesdeer #backcountryhunting #huntprep #huntersofinstagram #huntingpodcast #huntwest #findopportunity #huntarizona #huntaz

Why XRP Is Different | Real Markets, Energy & Trump This isn't about crypto hype. It's about power, freedom, and control. Tonight's stream breaks down why transparency has become a threat — not to people, but to global power brokers who rely on control, over-taxation, and manipulation to survive. We're watching a realignment happen in real time. When markets open… When value moves freely… When permission is no longer required… Systems built on gatekeeping start to panic — and they fight back. That's why this conversation matters now. We connect the dots between: Why XRP is different How open markets challenge centralized control Why DeFi represents economic freedom, not a trend How energy, borders, and production expose real power Why political narratives are breaking down globally This isn't speculation. It's a shift in who gets to participate in the economy. And the movie is just getting started.

Hoy arrancamos con el indulto de Wanda Vázquez y repasamos porque es la política con más suerte en la historia de la humanidad. Luego, más detalles del exejecutivo del del Banco Popular que aparente y alegadamente le robó $15M al banco.Entramos luego en lo último de la Reforma Contributiva: los que se mueven, los que se quedan fuera, y una Cámara que no trabajará la semana que viene mientras los numeritos siguen dando vueltas.Y sí, continúa el excelente ambiente laboral en el PNP. Si alguien pensó que enero iba a traer calma, se equivocó.En el chit-chat hablamos de los precios de las fiestas y del fin de la tregua entre Nydia Velázquez y Mamdani, porque la política no descansa ni en Nueva York ni en Puerto Rico.

Interview with Anodos Finance – Panos and Peter are ON THE CHAIN ********** ANODOS FINANCE Follow Anodos on X: https://x.com/AnodosFinance Follow Panos Mekras on X: https://x.com/panosmek Follow Peter Condilis on X: https://x.com/WinchesterXRP Learn more: https://anodos.finance/ XRP: The Anti-Bank Revolution You Weren't Told About https://x.com/panosmek/status/2012294306816545039 The Entrepreneurial Swamp Subtitle: Blockchain https://x.com/WinchesterXRP/status/2011896149037170809?s=20 Join the waitlist for the new super app https://anodos.finance/app ********** SUPPORT ON THE CHAIN GRAB A BADASS YETIS COFFEE – Fuel your crypto grind! ☕ Visit: badasserycoffee.com MINT YOUR BADASS YETIS NFT – Own a piece of the legend! Visit: otc.one/mint OTC MERCH IS HERE! – Represent the community in style! Visit: onthechain.shop BUY US A COFFEE – Help keep the content flowing! Visit: otc.one/buy-us-a-coffee JOIN THE CHANNEL – Get exclusive perks & behind-the-scenes content! Visit: otc.one/join ********** ON THE CHAIN – CONNECT WITH US! Listen to the OTC Podcast – Never miss an update! Visit: otc.one/podcast Visit Our Website – The home of crypto insights! Visit: onthechain.io Follow OTC on X – Stay updated in real time! Visit: otc.one/otc Join the OTC Community on Twitter – Be part of the discussion! Visit: twitter.com/i/communities/1599435678995062788 ********** FOLLOW THE OTC TEAM Follow Jeff on X:

For the first part of the episode description we usually say something funny, like Luke's salt and pepper beard. But this is an episode that we are so excited to release. While the Wyoming boys were on their western expedition, Luke was sitting on a few tags himself. And it wasn't until the boys tagged out that he starting looking for a deer himself. And not just a road forky, but a mule deer that makes you stop in your tracks and say "Damn, now THAT is a mule deer". And to add to the Mule deer success, less than 48 hours earlier, the boys quite literally stumbled into a herd of elk. A quick trip back into town for an OTC tag and a well executed 850 yard shot made for a long night. This is for sure a series of stories that you do not want to miss. 

Send Zorba a message!Dr. Zorba digs into two new studies that link food preservatives to cancer and type 2 diabetes. Zorba helps out listeners with vertigo, insomnia, and talks about the OTC nasal spray that helps with COVID. Zorba also pushes back against anti-science policies coming out of Washington, and we hear from the Italian faction of the Grammar Cops.Support the showProduction, edit, and music by Karl Christenson Send your question to Dr. Zorba (he loves to help!): Phone: 608-492-9292 (call anytime) Email: askdoctorzorba@gmail.com Web: www.doctorzorba.org Stay well!

Send Zorba a message!Dr. Zorba digs into two new studies that link food preservatives to cancer and type 2 diabetes. Zorba helps out listeners with vertigo, insomnia, and talks about the OTC nasal spray that helps with COVID. Zorba also pushes back against anti-science policies coming out of Washington, and we hear from the Italian faction of the Grammar Cops.Support the showProduction, edit, and music by Karl Christenson Send your question to Dr. Zorba (he loves to help!): Phone: 608-492-9292 (call anytime) Email: askdoctorzorba@gmail.com Web: www.doctorzorba.org Stay well!

Is the CLARITY Act Dead? | Greenland Worth More Than Denmark's GDP? Tonight we connect the dots between crypto regulation, political signaling, and global power plays.

Send us a textThe fastest tech in the world can't outpace human change, and that tension shows up as hearing aid returns. Blaise digs into a process-first approach that keeps patients engaged, supported, and satisfied without chasing the latest hardware. Drawing on years of private practice experience, he unpacks why returns are usually about expectations and support, and how small, deliberate shifts in language, follow-up, and outcome tracking can dramatically reduce churn.We start by reframing returns as feedback from the process. Patients arrive with Amazon-speed expectations, OTC noise shaping beliefs, and limited tolerance for friction. Instead of pushing harder, we slow down to set realistic optimism: hearing aids begin the change and the brain finishes it. You'll hear practical ways to normalize early challenges: own-voice changes, loud backgrounds, listening fatigue - so patients see them as milestones, not red flags.From there, we lay out a simple, repeatable system. Front load support with a 24-hour check-in, thoughtful texts, and one- and two-week follow-ups that signal presence without crowding schedules. Anchor goals to what matters most (family conversations, work meetings, faith services) and include the primary communication partner to build resilience at home. In follow-ups, treat every adjustment as information. Use data logging to guide open questions, not lectures, and bring in validated tools like the abbreviated profile of hearing aid benefit (APHAB) to make progress visible. Small wins compound when they're measured together.By the end, you'll have a clear playbook: shift from device language to process language, normalize early experiences, align on meaningful outcomes, and document a consistent journey from first call to six-month care. Technology fits ears, but communication fits lives. If this resonated, subscribe, share with a colleague who needs a lift, and leave a quick review so more hearing pros can find the show. What one change will you try this week? Connect with the Hearing Matters Podcast TeamEmail: hearingmatterspodcast@gmail.com Instagram: @hearing_matters_podcast Facebook: Hearing Matters Podcast

Kicking off the first episode of the To the Point podcast in 2026, co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, FAAO, continue the dry eye conversation with DED pearls to implement in clinic. They cover everything from patient signs, symptoms, and side effects to in-office tools, treatments, and therapeutics and OTC options.

Trump Power Move | Venezuela, Greenland, Iran & Crypto Most people are confused by what's happening right now. Venezuela. Iran. Greenland. Crypto. It all looks chaotic — disconnected — random. It isn't. Tonight, we break down what this really is: a global power move. This stream connects the dots between: • Venezuela and resource leverage • Iran, pressure from within, and regional instability • Greenland as a strategic choke point for trade, defense, and the Arctic • Why crypto and transparency matter when power, money, and influence are being reshuffled This isn't about headlines. It's about geography, resources, alliances, and leverage. If you're trying to understand how the U.S. is checking China and Russia — while reshaping global influence — this conversation will make the chessboard visible.

They Tried to Kill Crypto — Now They Need It | BNY & Ripple Change Everything Traditional finance spent years trying to shut crypto out. Now they're quietly moving on-chain. One of the world's oldest banks, BNY Mellon, has launched tokenized deposit services, bringing programmable, on-chain cash directly into the core of the banking system — with Ripple and Ripple Prime positioned as early adopters. This isn't hype. This is infrastructure. At the same time: Ripple secures UK FCA approval with an EMI license and cryptoasset registration Banks that once debanked crypto are now lobbying Congress to ban stablecoin rewards The UK debates banning X, triggering backlash over free speech and censorship Geopolitical tensions escalate — from Trump's Greenland comments to border enforcement showdowns and media meltdowns This episode connects the dots between: ✔️ On-chain banking ✔️ Regulatory clarity vs institutional panic ✔️ Tokenized deposits vs stablecoins ✔️ Free speech, capital flight, and geopolitical pressure Nothing happening right now is accidental. This is a power transition — and the old system didn't win.

XRP Demand Surge | Flare FXRP Launch | Somali Fraud is Global Tonight we're breaking down one of the strongest institutional positioning signals we've seen around XRP in years. Ripple leadership is talking openly about capital markets moving on-chain, stablecoins generating yield through direct + secondary utility, and growing institutional demand heading into 2025–2026. At the same time, CNBC is calling XRP the “hottest trade of the year,” while Flare launches FXRP spot exposure on Hyperliquid — opening a new liquidity and access rail. This isn't retail hype — this is financial infrastructure taking shape. TONIGHT'S TOPICS CRYPTO / XRP • Ripple SVP explains stablecoin yield + capital efficiency • Institutions preparing for capital markets on-chain • XRP positioned as core liquidity + settlement infrastructure • CNBC says XRP is the “hottest trade of the year” • Flare launches FXRP spot exposure on Hyperliquid MACRO / GEOPOLITICS • Byron Donalds exposes Minnesota Somali fraud scandal • Whistleblowers targeted as officials protected the fraud • What corruption + accountability mean in a digitizing economy No spin. No hopium. Just Pure Venom. SUPPORT ON THE CHAIN GRAB A BADASS YETIS COFFEE – Fuel your crypto grind! ☕ Visit: badasserycoffee.com MINT YOUR BADASS YETIS NFT – Own a piece of the legend! Visit: otc.one/mint OTC MERCH IS HERE! – Represent the community in style! Visit: onthechain.shop BUY US A COFFEE – Help keep the content flowing! Visit: otc.one/buy-us-a-coffee JOIN THE CHANNEL – Get exclusive perks & behind-the-scenes content! Visit: otc.one/join ********** ON THE CHAIN – CONNECT WITH US! Listen to the OTC Podcast – Never miss an update! Visit: otc.one/podcast Visit Our Website – The home of crypto insights! Visit: onthechain.io Follow OTC on X – Stay updated in real time! Visit: otc.one/otc Join the OTC Community on Twitter – Be part of the discussion! Visit: twitter.com/i/communities/1599435678995062788 ********** FOLLOW THE OTC TEAM Follow Jeff on X:

Andy sits down with Kanny Lee, CEO and co-founder of SecondSwap, to explore one of crypto's most under-discussed structural problems: liquidity for locked and vested tokens. With a background spanning two decades in Big Four forensic accounting and early institutional crypto OTC trading in Hong Kong, Kanny brings a rare blend of TradFi discipline and on-chain realism to the conversation. Why you should listen Kanny explains why crypto's evolution now demands proper secondary market infrastructure—something traditional finance has always relied on, but Web3 has largely ignored. SecondSwap is building a decentralized, on-chain marketplace that allows locked token positions to be traded without breaking vesting schedules, inflating supply, or undermining token integrity. By operating directly at the smart-contract layer, SecondSwap enables partial exits, discounted entry for new investors, and real liquidity where none previously existed. The discussion digs into "mid-life markets," token dump cycles, and the difference between superficial liquidity driven by short-term speculation versus sustainable liquidity built on conviction and patience. Kanny makes the case that healthy secondary markets could be a missing piece behind the stalled altcoin cycle—and that better liquidity design benefits founders, early investors, and new entrants alike. The conversation wraps with rapid-fire hot takes on Bitcoin maximalism, real-world assets, AI, privacy chains, and whether another alt season is still possible.  Supporting links Stabull Finance SecondSwap Andy on Twitter  Brave New Coin on Twitter Brave New Coin   If you enjoyed the show please subscribe to the Crypto Conversation and give us a 5-star rating and a positive review in whatever podcast app you are using.

RLUSD Locked-In | Trump Frees Venezuela | Democrats & Leftists Protest Tonight on On The Chain, we break down two parallel power shifts happening at the same time — one in finance, one in geopolitics.

XRP SUPPLY SHOCK | $1B ETFs Lock Supply | West Under Siege A real XRP supply shock is forming — and the data is getting impossible to ignore.

Las pruebas de drogas buscan detectar signos de drogas ilegales, ciertos medicamentos recetados y/o medicamentos de venta sin receta (conocidos como OTC por sus siglas en inglés) que pueden ser usados indebidamente.

Send us a textWe map a practical path from “is this dangerous?” to “what actually helps." We also talk about some specific headache types such as:  IIH, medication overuse, trigeminal neuralgia as well as the rise of CGRP therapies.• separating primary from secondary headache with SNOOP4• recognizing thunderclap, GCA, IIH, and low-pressure patterns• uncovering hidden chronic headache burden and medication overuse• exam essentials including fundoscopy and neck palpation• trigeminal neuralgia in MS and targeted MRI protocols• rescue strategy with effective OTC dosing and triptan timing• antiemetic choices matched to daily function• preventives matched to sleep, anxiety, weight, and goals• carbamazepine and oxcarbazepine for trigeminal neuralgia• role of acetazolamide and topiramate in pressure states• CGRP therapies, access hurdles, and practical selection• empowering patients with education, logs, and portable plansSupport the show Check out our website at www.theneurotransmitters.com to sign up for emails, classes, and quizzes! Would you like to be a guest or suggest a topic? Email us at contact@theneurotransmitters.com Follow our podcast channel on

No 221o BlockTalks a gente fala com André Franco, CEO da Boost Research, que conta como é o processo de análise da economia das blockchains.Links:https://www.linkedin.com/in/andre-franco/https://www.linkedin.com/company/boostresearch/https://boostresearch.com.br/https://x.com/21andrefranco1https://www.instagram.com/cryptoandrefrancohttps://www.youtube.com/@boostresearchThe BlockDrops Podcast is proud to be supported by Semoto.Semoto is the largest B2B ecosystem in Web3, built around three verticals.First, a curated marketplace that lets you quickly discover, compare, and review the best crypto providers and products.Second, independent consulting that runs your project management and vendor selection, so complex launches stay on time and on budget.Third, a boutique desk that helps you design and execute complex OTC transactions with true white-glove support, so you're never alone on the hardest decisions.Check https://semoto.io for more. Redes sociais / comms.. https://blockdropspodcast.xyz/.. https://blockdrops.substack.com .. Instagram.com/blockdropspodcast.. Twitter.com/blockdropspod.. Blockdrops.lens .. https://warpcast.com/mauriciomagaldi.. youtube.com/@BlockDropsPodcast.. Meu conteúdo em inglês twitter.com/0xmauricio.. Newsletter do linkedin  https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7056680685142454272.. blockdropspodcast@gmail.com

On today's Good Day Health Show - ON DEMAND…Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health. First up, Doug and Dr. Ken begin with what he sees from patients after the first of the year. Primarily, part of New Year's Resolutions include a focus on health, with people coming into the doctor's office more often to check in on their health, especially with the overindulgence from the holiday season. January, in general, is a time of huge interest in one's health. Then, the conversation shifts to a lab-grown heart, creating hopeful treatments for the future to regrow human organs. Continuous research and trials are intended to lead to successful transplants without needing donor waiting lists. Next up, Doug and Dr. Ken dive into Myasthenia Gravis (MG), a chronic autoimmune disease causing fluctuating weakness in voluntary muscles (eyes, face, swallowing, limbs) that worsens with activity and improves with rest, due to nerve signals being blocked from reaching muscles by the immune system. There is now a FDA approved treatment offering new hope to patients with MG. Shifting focus to mental health, a review finds some patients are able to safely taper off some of the antidepressants, a new hope following criticism that once you got on these drugs you can't get off of them. Rounding out the conversation, listener questions are addressed, including the dangers of hair loss pills and potential benefits of topicals over consumed OTC or prescribed medications, surprising benefits of vitamin D that go beyond bone health, if women should exercise differently than men or if age matters more than sex, and more.  Website: GoodDayHealthrShow.com Social Media: @GoodDayNetworks

Dive into an atmospheric mix of the latest Deep House, Afro House, and Chill House tracks — perfect for a romantic dinner, a touch of melancholy, or simply a moment of pure relaxation. Hosted by Lexolee, a singer and songwriter with a passion for emotional, melodic soundscapes. Discover fresh releases from rising talents and iconic names of the genre. ⚡️Like the Show? Click the [Repost] ↻ button so more people can hear it!

1:55 年底前量縮，正確來說是「實質週轉率」的數據觀察 4:18 台股今年的上市週轉率特別低，量縮特別嚴重 5:20 OTC相對過往幾年還好，原因就是壽險賣壓與結帳 7:15 台美股選擇權波動度也來拿到今年最低 9:00 12月內資熱門股要留意量滾量滾不上去，漲多補跌拉回 11:24 主動式ETF是今年台股籌碼最不一樣的勢力 13:33 ETF買盤導致的流動性緊張，助漲在年底量縮會特別明顯 15:20 12月主動ETF買盤來自新募資的建倉買盤，而非老ETF 16:30 12/30兩檔掛牌之後，3個月內無台股主動ETF新兵 17:40 持股高度集中，都是買AI股，助漲助跌自然會明顯 20:40 年底之後ETF的申購/買盤籌碼將進入一段真空期 22:31 00991A當例子，看建倉買盤的時段，前5後2應為基準 25:50 00990A嚴重溢價3~4%，非理性買盤失控… 28:20 漲多AI標的的調節力道，如果大盤開低助漲轉助跌!? 相關文章與圖表連結: https://www.big-econ.com/index.php?sec=article&ID=4042 -- Hosting provided by SoundOn

【主なニュース】▽OTC類似薬 患者の追加負担 対象となる77成分の案示す 厚労省　▽「子供PSCマーク」とは？3歳未満のおもちゃに新規制　▽名古屋 出張中の愛媛県警の警察官など 豊臣秀吉像の首折ったか　など

「医療保険制度改革で大詰め議論　出産費用は無償化も「ロキソニン」などOTC類似薬は保険適用のまま「特別料金」に」　出産費用の無償化や、市販薬と効能が似た「OTC類似薬」の追加負担などをまとめた医療保険制度の改革案について、大詰めの議論が行われています。出産費用は現在、「出産育児一時金」が支給されていて、「正常分娩（ぶんべん）」では、保険診療の対象外です。厚生労働省は、「一時金」に代わって出産費用を全国一律にした上で、公的医療保険で全額まかなう案を示しています。また、すべての妊婦に現金給付する方向で、帝王切開などは保険診療が適用され、3割の自己負担が生じることから、負担軽減の狙いがあるとみられます。一方、「OTC類似薬」については、77成分を対象に保険適用を維持したまま、「特別料金」を支払うことを求め、2026年度中に実施する方針です。

「医療保険制度の改革案について大筋了承「出産費用無償化」「OTC類似薬負担」など」　出産費用の無償化や市販薬と効能などが似た「OTC類似薬」の追加負担などをまとめた医療保険制度の改革案について、大筋で了承されました。出産費用は現在、「出産育児一時金（50万円）」が支給されていて、「正常分娩」では保険診療の対象外となり、物価高を理由に費用は上昇しています。厚生労働省の審議会は25日、「一時金」に代えて出産費用を全国一律にした上で、公的医療保険で全額まかなう案を大筋で了承しました。また、全ての妊婦に現金給付をする方針で、保険診療により3割の自己負担が生じる帝王切開などで負担を軽減する狙いがあるとみられます。早ければ2026年の通常国会に法案を提出する方針です。一方、保険適用されるものの成分や効能が市販薬と似ている「OTC類似薬」について、鎮痛剤のロキソニンや抗アレルギー薬のアレグラなどを対象に保険適用を維持したまま、利用者に「特別料金」を支払うことを求め、2026年度中に実施する方針です。

In the 220th BlockTalks we speak with Ed Hesse, Co-Founder & CEO of Energy Web, who tells us how blockchain is transforming the energy sector. Links:Ed's LinkedIn https://www.linkedin.com/in/edhesse/Energy Web LI: https://www.linkedin.com/company/energywebx/Energy Web site: https://energyweb.org/Energy Web on Twitter: https://x.com/energywebxEd on Twitter: https://x.com/edhesse79The BlockDrops Podcast is proud to be supported by Semoto.Semoto is the largest B2B ecosystem in Web3, built around three verticals.First, a curated marketplace that lets you quickly discover, compare, and review the best crypto providers and products.Second, independent consulting that runs your project management and vendor selection, so complex launches stay on time and on budget.Third, a boutique desk that helps you design and execute complex OTC transactions with true white-glove support, so you're never alone on the hardest decisions.Check https://semoto.io for more. Redes sociais / comms.. https://blockdropspodcast.xyz/.. https://blockdrops.substack.com .. Instagram.com/blockdropspodcast.. Twitter.com/blockdropspod.. Blockdrops.lens .. https://warpcast.com/mauriciomagaldi.. youtube.com/@BlockDropsPodcast.. Meu conteúdo em inglês twitter.com/0xmauricio.. Newsletter do linkedin  https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7056680685142454272.. blockdropspodcast@gmail.com

Note that this is from a video essay published on YouTube here.For over a year, I've been helping people send aid to Gaza via cryptocurrency because traditional banking systems have failed Palestinians. PayPal and GoFundMe freeze accounts, banks block transfers, and those that go through can take weeks or months. Cryptocurrency offers instant, censorship-resistant transfers that offer higher guarantees.This comprehensive guide covers three methods for sending crypto (SimpleSwap, Revolut, and zkP2P), how to avoid tax complications when fundraising, critical safety tips to prevent irreversible mistakes, and everything you need to know about wallets, networks, and the OTC desk system in Gaza.

「「OTC類似薬」患者が追加負担へ　医療費約1880億円を削減」　自民党と日本維新の会は、市販薬と効能が似ている「OTC類似薬」の患者負担見直しで合意しました。自民党・小林政調会長：現役世代の負担軽減の側面でもある一方で、一定の配慮のもとに患者の方にもご負担いただく。維新は、現役世代の社会保険料負担を軽減するため、OTC類似薬の保険適用見直しを求め、自民党と協議していました。合意では、保険適用を維持したまま、湿布やアレルギー薬などの77成分、約1100品目を対象に薬価の1/4を特別料金負担に設定して患者負担を求めます。子供や難病患者などの要配慮者は負担の対象外になる見通しで、ほかの取り組みと合わせて約1880億円の医療費が削減される見通しです。

Why XRP Is Winning: Payments, ETFs & U.S. Trust Bank Approval Ripple is quietly winning where it matters most. Tonight we break down why XRP is pulling ahead — from real-world payments and enterprise adoption to 30 straight days of XRP spot ETF inflows and Ripple's U.S. Trust Bank approval. We cover: • Why XRPL payments solve real banking pain • How visibility beats speed in cross-border settlement • What XRP ETFs signal about institutional demand • The Ripple escrow debate under the CLARITY Act • Why U.S. regulatory approval changes everything • How RLUSD could become a top global stablecoin This isn't hype — it's infrastructure, regulation, and capital moving in real time. SUPPORT ON THE CHAIN GRAB A BADASS YETIS COFFEE – Fuel your crypto grind! ☕ Visit: otc.one/BadassYetisBrew MINT YOUR BADASS YETIS NFT – Own a piece of the legend! Visit: otc.one/mint OTC MERCH IS HERE! – Represent the community in style! Visit: onthechain.shop BUY US A COFFEE – Help keep the content flowing! Visit: otc.one/buy-us-a-coffee JOIN THE CHANNEL – Get exclusive perks & behind-the-scenes content! Visit: otc.one/join ********** ON THE CHAIN – CONNECT WITH US! Listen to the OTC Podcast – Never miss an update! Visit: otc.one/podcast Visit Our Website – The home of crypto insights! Visit: onthechain.io Follow OTC on Twitter – Stay updated in real time! Visit: otc.one/otc Join the OTC Community on Twitter – Be part of the discussion! Visit: twitter.com/i/communities/1599435678995062788 ********** FOLLOW THE OTC TEAM Follow Jeff on Twitter:

In the 219th BlockTalks we speak with Avinash Lakshman, Founder & CEO of Weilliptic, who tells us about his journey from distributed storage to decentralized networks.Links:X Link: https://x.com/weillipticLinkedIn Link: https://www.linkedin.com/company/weilliptic/Website Link: https://weilliptic.ai/The BlockDrops Podcast is proud to be supported by Semoto.Semoto is the largest B2B ecosystem in Web3, built around three verticals.First, a curated marketplace that lets you quickly discover, compare, and review the best crypto providers and products.Second, independent consulting that runs your project management and vendor selection, so complex launches stay on time and on budget.Third, a boutique desk that helps you design and execute complex OTC transactions with true white-glove support, so you're never alone on the hardest decisions.Check https://semoto.io for more.. Redes sociais / comms.. https://blockdropspodcast.xyz/.. https://blockdrops.substack.com .. Instagram.com/blockdropspodcast.. Twitter.com/blockdropspod.. Blockdrops.lens .. https://warpcast.com/mauriciomagaldi.. youtube.com/@BlockDropsPodcast.. Meu conteúdo em inglês twitter.com/0xmauricio.. Newsletter do linkedin  https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7056680685142454272.. blockdropspodcast@gmail.com

Kumaran Vijayakumar has spent his career in the equity derivatives market, first as an exotics trader and later in running large risk-taking desks in listed and OTC options. Now, the CEO of DataDock Solutions, a firm he Co-Founded in 2018, Kumaran and his team are developing analytical tools that allow sell-side flow desks to better understand the risks they take and clients they take it for. Our discussion explores the challenges inherent in evaluating client flow, and how data-centric infrastructure has changed the way risk is assessed. With the premise that “what you can measure you can manage and improve”, we discuss DataDock's efforts to build tools capable of ingesting large-scale trade history and simulating outcomes at the most granular level. In equity derivatives, where trades move quickly and visibility is often instantaneous, desks have historically made decisions based on memory and anecdotal assessments of “good” versus “bad” flow. Kumaran describes this as a space where information is abundant, but structured insight often lags execution speed. Our discussion highlights a key theme: not all flow that loses money is detrimental, and not all flow that is profitable is necessarily strategic. Instead, Kumaran notes that client value emerges when one analyzes trade behavior across time, including delta hedge quality, volume risk transfer, roll probability, expected event-driven distribution, and the role of flow as portfolio offset rather than standalone P&L. I hope you enjoy this episode of the Alpha Exchange, my conversation with Kumaran Vijayakumar.

In this episode we recap Bobs slam dunk of the season, His giant OTC public land white tail hunt from Idaho. This buck was a truly magical moment for the guys, Bob has struggled all season and it finally came together at the very end of the year on the last hunt of the season!! Enjoy this episode!      CHECKOUT OUR YOUTUBE BELOW! https://www.youtube.com/@PNWild/videos SUBSCRIBE TO OUR YOUTUBE CHANNEL https://www.youtube.com/c/PNWild   FOR GOHUNT use code PNW thise code will give you $50 in GOHUNT Shop credit when you purchase an Insider Membership and $20 when they purchase an Explorer Membership and 10% off the GoHunt gear shop!   VISIT OUR LINKTREE FOR ALL OUR DISCOUNT CODES!! https://linktree/pnwild PNWILD STORE - USE CODE PODCAST AT CHECKOUT

Contributor: Meghan Hurley, MD Educational Pearls:  OTC Medications Dextromethorphan (DM) Most common OTC cough suppressant Minimal efficacy: Little evidence that it shortens the duration or severity of cough. Potential side effects: At recommended doses: Mild dizziness, drowsiness, GI symptoms Higher doses: Decreased consciousness, dissociative effects Guaifenesin Found in Mucinex and other severe cough/cold products Thins secretions and loosens mucus in airways No more effective than increasing oral fluid intake Prescription Medications Codeine-containing products Suppresses cough center in the medulla Metabolized via CYP2D6 with significant differences in metabolism between individuals: Low metabolizers experience little effect, high metabolizers have risk of increased toxicity Benzonatate (Tessalon Perles) Topical anesthetic; inhibits pulmonary stretch receptors and reduces cough reflex. Efficacy is mixed; no clear benefit over placebo. Precautions: do not bite or chew; dangerous in children

Michael Carbonara - Live Interview – Candidate for U.S. House of Representatives, Florida 25 Michael Carbonara is a South Florida entrepreneur, husband, and father running for Congress in Florida's 25th District. Raised in a working‑class, faith‑centered household in New York, he built companies that create jobs and solve real problems. From payments and banking to genetics and fertility care. After moving to Florida in 2012, Carbonara and his wife, whose family fled Castro's Cuba, put down roots and are raising two daughters. Carbonara is running to restore affordability, defend constitutional freedoms, and put public safety first. He brings a builder's mindset: cut red tape, spur innovation, and make the government accountable so families and small businesses can thrive. Website: https://michaelcarbonara.com/ Follow Michael: ● X: https://x.com/MCarbonaraFL ● Instagram: https://www.instagram.com/mcarbonarafl/ ● LinkedIn: https://www.linkedin.com/in/michaelcarbonara/ ● Facebook: https://www.facebook.com/profile.php?id=61578435752040 ● YouTube: https://youtube.com/@mcarbonarafl25?si=YAAP01IbL4puK4EI ----- SUPPORT ON THE CHAIN GRAB A BADASS YETIS COFFEE – Fuel your crypto grind! ☕ Visit: otc.one/BadassYetisBrew MINT YOUR BADASS YETIS NFT – Own a piece of the legend! Visit: otc.one/mint OTC MERCH IS HERE! – Represent the community in style! Visit: onthechain.shop BUY US A COFFEE – Help keep the content flowing! Visit: otc.one/buy-us-a-coffee JOIN THE CHANNEL – Get exclusive perks & behind-the-scenes content! Visit: otc.one/join ********** ON THE CHAIN – CONNECT WITH US! Listen to the OTC Podcast – Never miss an update! Visit: otc.one/podcast Visit Our Website – The home of crypto insights! Visit: onthechain.io Follow OTC on Twitter – Stay updated in real time! Visit: otc.one/otc Join the OTC Community on Twitter – Be part of the discussion! Visit: twitter.com/i/communities/1599435678995062788 ********** FOLLOW THE OTC TEAM Follow Jeff on Twitter:

http://www.TaxSaleAcademy.com-Most people assume OTC Tax Sale properties are the easiest way to find cheap deals with no competition. That belief is exactly what gets so many investors stuck with properties they can't sell. In this video, I break down the real truth about OTC investing, why it's far harder than it looks, and what actually separates the people who succeed from the ones who get frustrated and quit. OTC can be very profitable when approached the right way, but it's not a shortcut and it's not for everyone. If you've ever wondered whether OTC is a hidden opportunity or a hidden trap, this episode will help you see it clearly.Come join our Training Platform & Community at http://TaxSaleAcademy.com

In the 218th BlockTalks we speak with Wojtek Pawlowski, CEO & Co-Founder at Accountable, who explains how to build conviction in the wake of lessons learned.Links:Website https://www.accountable.capital/ Socials:https://x.com/AccountableDatahttps://x.com/VVojtek_Phttps://www.linkedin.com/company/accountablecapital/https://www.linkedin.com/in/wojtek-pawlowski-accountable/Additional resources: https://accountabledata.substack.com/p/fueling-the-next-phase-of-verifiedhttps://www.accountable.capital/proof-of-solvencyThe BlockDrops Podcast is proud to be supported by Semoto.Semoto is the largest B2B ecosystem in Web3, built around three verticals.First, a curated marketplace that lets you quickly discover, compare, and review the best crypto providers and products.Second, independent consulting that runs your project management and vendor selection, so complex launches stay on time and on budget.Third, a boutique desk that helps you design and execute complex OTC transactions with true white-glove support, so you're never alone on the hardest decisions.Check https://semoto.io/ for more. Redes sociais / comms.. https://blockdropspodcast.xyz/.. https://blockdrops.substack.com .. Instagram.com/blockdropspodcast.. Twitter.com/blockdropspod.. Blockdrops.lens .. https://warpcast.com/mauriciomagaldi.. youtube.com/@BlockDropsPodcast.. Meu conteúdo em inglês twitter.com/0xmauricio.. Newsletter do linkedin  https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7056680685142454272.. blockdropspodcast@gmail.com

When auditing risk of management in an E/M note, how are over-the-counter (OTC) medications scored? Under the 1995/1997 guidelines, they were categorized in the “low” risk row. However, the 2021 guidelines provide no examples under minimal or low risk, relying instead on AMA and Medicare guidance. Terry explains this distinction and highlights the difference between an acute uncomplicated illness and an acute illness with systemic symptoms. Take a listen. Subscribe and Listen You can subscribe to our podcasts via: Apple Podcasts – https://podcasts.apple.com/us/podcast/codecast-medical-billing-coding-insights/id1305926627 Spotify – https://open.spotify.com/show/1lA69Q7EnjSMuVr3sXVWlX TuneIn – https://tunein.com/radio/CodeCast–Medical-Billing-p1056702/ YouTube – https://www.youtube.com/channel/UCoNm5vs6PFMIEDa5Undidlg YouTube Music – https://www.youtube.com/playlist?list=PLQ8tk23yZroZslhtTVe-PEIjQsAoJZJIQ Pandora – https://www.pandora.com/podcast/codecast-medical-billing-and-coding-insights/PC:1000156874 Amazon Podcasts – https://music.amazon.com/podcasts/c9d8dc99-fced-45a2-82b4-0efdf144c897/CodeCast-Medical-Billing-and-Coding-Insights iHeart Radio – https://www.iheart.com/podcast/256-codecast-medical-billing-a-31135434/ The post “Risk” E/M Element OTC Medications appeared first on Terry Fletcher Consulting, Inc..

Pain relief medications like acetaminophen and ibuprofen are staples in everyday care—but emerging research suggests they may play a role in antibiotic resistance. This episode reviews recent findings, explores how these common drugs may influence bacterial response to antibiotics, and highlights pharmacist‑specific considerations. You will walk away with practical insights to support informed medication use and strengthen antibiotic stewardship.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTHunter O. Rondeau, PharmD, BCIDP, AAHIVPAntimicrobial Stewardship Coordinator, SSM HealthAdjunct Clinical Assistant Professor, University of Kansas School of PharmacyRachel Maynard has no relevant financial relationships with ineligible companies to disclose. Hunter Rondeau is a consultant for Pyrls, a speaker for ASHP, and was a speaker for ACCP (ended October 2025) and Vituity (ended May 2025). All relevant financial relationships have been mitigated.Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe emerging evidence on how common OTC pain medications may influence antibiotic resistance.2. Identify pharmacist strategies to optimize analgesic and antibiotic use while supporting antimicrobial stewardship.0.05 CEU/0.5 HrUAN: 0107-0000-25-372-H01-PInitial release date: 12/8/2025Expiration date: 12/8/2026Additional CPE details can be found here.

Pain relief medications like acetaminophen and ibuprofen are staples in everyday care—but emerging research suggests they may play a role in antibiotic resistance. This episode reviews recent findings, explores how these common drugs may influence bacterial response to antibiotics, and highlights pharmacist‑specific considerations. You will walk away with practical insights to support informed medication use and strengthen antibiotic stewardship.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsHunter O. Rondeau, PharmD, BCIDP, AAHIVPAntimicrobial Stewardship Coordinator, SSM HealthAdjunct Clinical Assistant Professor, University of Kansas School of PharmacyRachel Maynard has no relevant financial relationships with ineligible companies to disclose. Hunter Rondeau is a consultant for Pyrls, a speaker for ASHP, and was a speaker for ACCP (ended October 2025) and Vituity (ended May 2025). All relevant financial relationships have been mitigated. CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here.CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe emerging evidence on how common OTC pain medications may influence antibiotic resistance.2. Identify pharmacist strategies to optimize analgesic and antibiotic use while supporting antimicrobial stewardship.0.05 CEU/0.5 HrUAN: 0107-0000-25-372-H01-PInitial release date: 12/8/2025Expiration date: 12/8/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

2025 has been the most disruptive year hearing care has seen in a decade, from Apple's expanded ecosystem and a confusing OTC landscape, to AI-driven marketing, shifting patient expectations, staffing shortages, and clinics learning (sometimes painfully) what actually drives growth. In this episode, we break down the biggest lessons of the year, what the data really shows, and where clinics should focus going into 2026. In this episode: What Apple's 2025 updates actually changed for hearing care Why OTC is still confusing patients, and how clinics can respond The AI tools that saved practices… and the ones that flopped The staffing crisis no one is talking about The MVP insights: revenue trends, conversion patterns & the winners of 2025 What will matter MOST in 2026 (and what won't) If you want a grounded, no-nonsense look at what's working in private practice right now, this one's for you. Learn more at orange-gray.com

My big brother and I don't look alike, yet we have a common thread: a passion to help others get healthier from the inside out! Today we head first into the following: Why “flu season” isn't real—and what's actually happening in your body during colder monthsSupplements--are OTC ok? If so, what to look for?The two key words that can keep you on track with your health goals through the holidays (especially when the cookies and casseroles start calling

The Week 13 NFL slate was a gross one after all of the premium games of the week were taken by Thanksgiving and Black Friday. Somehow, AD Mitchell was the guy you needed. Big weeks from Brock Bowers and Trey McBride were also useful across the DFS and best ball landscape.

In this episode, we cover institutional crypto adoption, stablecoins' interplay with treasuries and 24/7 repo financing on Canton, the risks associated with wrapped assets and stablecoin fragmentation, and 2026 expectations for broader, client-driven OTC and onchain activity.   -- Quadrillions brings together the voices defining the next era of finance. From institutional rails to stablecoins and privacy, the series dives into how traditional markets, crypto innovation, and regulatory frameworks are converging to bring the full force of capital markets onchain. Join hosts Jason Yanowitz, Yuval Rooz, and Eric Saraniecki for deep dives with special guests Shaul Kfir, Don Wilson, Mike Belshe, Justin Peterson, Acting Chair Caroline Pham, Eli Ben-Sasson, and more. Produced by Blockworks and Canton Network. For more information, check out https://quadrillionspod.com/ -- Follow Canton: https://x.com/CantonNetwork Follow Tradeweb: https://x.com/Tradeweb Follow Mike: https://x.com/mikebelshe Follow Eric: https://x.com/wesarn_real Follow Empire: https://twitter.com/theempirepod -- Timestamps: (0:00) Introduction (1:38) Tradeweb's Origin Story (3:58) The State of Institutional Crypto Adoption (8:23) Where is the Most Growth Right Now? (10:26) Consolidating Stablecoins (15:23) Tradeweb's Crypto Strategy (18:32) What Does Crypto Solve Today? (23:37) The Next 100x Growth Opportunity (27:56) Bringing RWAs Onchain (31:25) The Role of Custodians (35:03) Canton's Go-to-market Strategy (38:31) Tokenized Equities (44:02) The Need For Privacy (49:23) Crypto Adoption Going Forward -- Disclaimer: “Quadrillions” is a mini-series produced by Blockworks, and is sponsored by Canton Network. Nothing on this show is a recommendation to buy or sell securities or tokens. It's for informational purposes only, and the views expressed by anyone on the show are solely their opinions, not financial advice or necessarily the views of Blockworks. Our hosts, guests, and the Blockworks team may hold positions in companies, funds, or projects discussed, including those related to Canton Network.